Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment

Catherine H. Choi, Brian P. Schoenfeld, Aaron J. Bell, Paul Hinchey, Maria Kollaros, Michael J. Gertner, Newton H. Woo, Michael R. Tranfaglia, Mark F. Bear, R. Suzanne Zukin, Thomas V. McDonald, Thomas A. Jongens, Sean M.J. McBride

Research output: Contribution to journalArticlepeer-review

80 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences